Klor-Con Powder for oral solution is available as packets that contain 1.5g of potassium chloride (supplying potassium 20mEq and chloride 20mEq) in 30- and 100-count cartons. Upsher-Smith announced ...

Strides Pharma Science Limited (Strides) has announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has received approval for Potassium Chloride for Oral ...

June 24, 2009 — On June 17, the US Food and Drug Administration (FDA) approved diclofenac potassium for oral solution (Cambia, marketed by Kowa Pharmaceuticals America, Inc, under license from Applied ...

Depomed to host investor conference call today at 5:00 p.m. EST, 2:00 p.m. PST "CAMBIA, our third product acquisition in 18 months, is a unique and fast acting treatment for migraine with long-term ...

DUBLIN, Sept. 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced new real-world evidence and Phase 4 data reinforcing the value of Xywav® (calcium, magnesium, potassium, ...

MAPLE GROVE, Minn., Nov. 28, 2017 /PRNewswire/ -- Upsher-Smith Laboratories, LLC. (Upsher-Smith) today announced the launch of KLOR-CON ® Powder (Potassium Chloride) for oral solution, 20 mEq. The ...

The approved product is bioequivalent to the reference listed drug Potassium Chloride Oral Solution of Genus Lifesciences, Inc. Advisory Alert: It has come to our attention that certain individuals ...

Strides Pharma Science Limited (Strides) has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Potassium Chloride Oral ...

Granules India Limited announced today that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI)., a ...

Drug firm Strides Pharma Science on Monday said its step-down subsidiary, Strides Pharma Global Pte Ltd, has received approval from the US health regulator for potassium chloride for oral solution, ...